The authors examined the impact of prenatal diagnosis and elective termination of neural tube defect (NTD)-affected pregnancies on NTD prevalence and risk estimates. Prevalence data were actively ascertained and were derived from a population-based 1989-1991 cohort of California births. Included were 664 singleton infants/fetuses with an NTD. The birth prevalence (livebirths and stillbirths only) was 48.4% of the total prevalence (including elective terminations) for anencephaly and 70.2% for spina bifida. The authors also used in-person interview data from mothers of 538 of the ascertained NTD cases and mothers of 539 randomly selected nonmalformed control infants to examine maternal/infant characteristics. Compared with women who delivered liveborn/stillborn infants with an NTD, women who electively terminated NTD-affected pregnancies were disproportionately white, were more highly educated, had higher incomes, and used vitamins containing folic acid more often. For factors associated with elective terminations, risk estimates appeared biased when only livebom and stillborn infants were included among cases compared with analyses in which all clinically recognized NTD-affected pregnancies were included. Am J Epidemiol 1996;144:473-9.
Neural tube defects (NTDs) occur in approximately one in every 1,000 births in the United States (1) and contribute substantially to childhood morbidity and fetal and infant mortality (2, 3) . However, with the exception of a decreased NTD risk associated with maternal periconceptional vitamin intake (4, 5) , very little is known about the etiology of NTDs (6) .
To obtain the incidence of NTDs in a particular population and to identify causal factors in that population, ideally all NTD-affected conceptuses should be ascertained (7) (8) (9) (10) (11) (12) . However, because early pregnancy losses and elective terminations are difficult to ascertain, many studies include only livebirths or livebirths and stillbirths (1) . Inclusion of only these pregnancies is increasingly problematic because the proportion of NTDs identified prenatally and electively terminated has increased steadily in industrialized countries since the late 1970s (13) . Additionally, women who have access to and who utilize prenatal screening and elective termination procedures may have characteristics different from those who do not.
Prevalence estimates based solely on livebirths and stillbirths may thus be less useful for monitoring trends in NTD prevalence estimates across and/or within populations (14) . Further, selection bias may be present in studies limited to livebirths and stillbirths if studied risk factors distribute differently between women who electively terminate and those who do not.
With population-based data from a cohort of over 700,000 California births, the objectives of this study were to 1) examine the impact of elective termination of NTD-affected fetuses on the NTD birth prevalence; 2) compare characteristics of women who electively terminated NTD-affected fetuses with those who delivered livebom or stillborn infants with an NTD; and 3) examine the potential bias in NTD risk estimation from incomplete ascertainment of clinically identified NTD-affected pregnancies.
MATERIALS AND METHODS

Case ascertainment
All livebom, stillborn (S:20 weeks gestation), electively terminated, and spontaneously aborted clinically recognized infants or fetuses with an NTD (anencephaly, spina bifida, craniorrhachischisis, or iniencephaly) were ascertained by the California Birth Defects Monitoring Program (15) . The Program reviewed medical records at all nonmilitary hospitals and prenatal/ genetic centers included in the population base (statewide except for Los Angeles, Ventura, and Riverside counties). Records reviewed included the Diagnoses Index, labor/delivery, nursery, nursery intensive care unit, pediatric, pediatric intensive care unit, surgery, stillbirth, and pathology records (15) . Cases terminated in the prenatal period were identified from ultrasound (often done as follow-up to positive maternal serum alpha-fetoprotein screening (MSAFP)) and cytogenetic laboratory records ascertained either from prenatal/genetic center records or hospital records. Singleton infants diagnosed with an NTD between June 1, 1989, and May 31, 1991, and singleton fetuses diagnosed prenatally with an NlD and spontaneously or electively terminated between February 1, 1989 and January 31, 1991, were eligible. (These time frames reflected similar dates of conception for infants and fetuses.) A total of 664 singleton infants/fetuses with an eligible NTD were ascertained.
Assessment of delivery status
Delivery status was derived from medical records, when available, and was defined as: livebirth, a delivery in which the fetus/infant took at least one breath; stillbirth, a delivery at 20 weeks or more gestation in which the fetus/infant had died prior to delivery; and elective termination, a delivery at less than 20 weeks gestation in which the fetus/infant was induced or surgically removed from the womb (regardless of whether the fetus was alive or dead prior to termination) or a delivery at 20 or more weeks gestation in which the fetus was alive prior to delivery and was induced or surgically removed from the womb. There were no spontaneous deliveries less than 20 weeks gestation ascertained. When delivery status information for interviewed case mothers was not available from the medical record, maternal report was used (n = 54, 11 livebirths at term or near term and 43 elective terminations at around 20 weeks gestation). For seven noninterviewed cases, delivery status could not be determined. Gestational age estimates were primarily derived from the medical record, except that when this information was not available on the medical record (n = 54), maternal report was used.
Prevalence estimates
Birth prevalence was defined as the number of NTD-affected livebirths and stillbirths per 1,000 livebirths and stillbirths. Total prevalence was defined as the number of clinically recognized NTD-affected spontaneous abortions, elective terminations, livebirths, and stillbirths per 1,000 livebirths and stillbirths. The total number of liveborn and stillborn infants for the study period and geographic area was obtained from California vital statistics records (n = 708,129).
Case population characteristics and risk estimations
Maternal in-person interview information from a population-based case-control study of parental risk factors for NTDs was used to determine whether characteristics of electively terminated, NTD-affected infants/fetuses were similar to those of NTD-affected infants who were liveborn or stillborn. This information was also used to compare risk estimates in which only liveborn and stillborn infants were included among cases with risk estimates in which all identified NTD-affected pregnancies were included. Details of the case-control study design and data collection appear elsewhere (16) . Eligible cases were those described above for the prevalence analyses. Eligible controls were nonmalformed, liveborn infants randomly selected from a geographic area and time frame similar to that of the cases. In addition, women who spoke only languages other than English or Spanish (26 cases and 32 controls) or who were ascertained after all case-control interviews had been completed (14 cases) were not eligible for study. Interviews were completed for 549 (88.0 percent of 624 eligible) case mothers and for 540 (88.2 percent of 612 eligible) control mothers. Nonparticipants were similar to study participants in maternal age and ethnic origin, as well as NTD case type and pregnancy delivery status. Inperson interviews were completed an average of 4.9 months for cases and 4.6 months for controls from the actual or estimated date of delivery. Among the 1,089 women who completed the interview, 12 women (including 11 case mothers) had a previous NTD-affected pregnancy and were excluded from analyses because they were suspected of having a different etiology and there was inadequate sample size to examine them separately. Included in population characteristic and risk estimate analyses were 538 cases and 539 controls.
We examined the following characteristics: maternal ethnic origin (white non-Latina, US-born Latina, foreign-born Latina, black, other); maternal age (^19, 20-24, 25-29, 30-34, and >35 years); gravidity (1,2, 3, or ^4); highest maternal educational diploma received (less than high school diploma, high school diploma/vocational certificate, 2-or 4-year college degree); yearly household income (^$9,999, $10,000-29,999, $30,000-49,999, and >$50,000); maternal periconceptional employment (i.e., in the 3 months before or after conception) (yes, no); initiation 
Data analysis
Crude maximum likelihood odds ratios and their corresponding 95 percent confidence intervals were computed using EGRET software (18) . Percentages and 95 percent confidence intervals for single proportions were calculated in accordance with Fleiss (19) .
RESULTS
Prevalence estimates
The NTD total prevalence was 0.94 per 1,000 livebirths and stillbirths, including seven cases with unknown delivery status (n = 664). In contrast, the NTD birth prevalence was 0.56 per 1,000 livebirths and stillbirths, representing 60.4 percent of the total prevalence (table 1) . For anencephaly, the birth prevalence was 0.19 per 1,000 livebirths and stillbirths, 48.4 percent of the total anencephaly prevalence. For spina bifida, the birth prevalence was 0.35 per 1,000, 70.2 percent of the total spina bifida prevalence, and for all other NTDs the birth prevalence was 0.02 per 1,000, 57.7 percent of the total prevalence for all "other" NTDs.
Population characteristics among NTD-affected pregnancies
Among the 538 interviewed case mothers, 40.0 percent electively terminated their pregnancies (n = 215), and 60.0 percent delivered liveborn (n = 267) or stillborn (n = 56) infants. Among electively terminated pregnancies, 54 percent (n = 116) were 20 weeks or more gestation.
Maternal/infant characteristics of pregnancies electively terminated differed substantially from those delivered liveborn or stillborn ( anencephaly; 2) substantial differences in maternal and infant characteristics existed between women who electively terminated NTD-affected pregnancies and those who delivered liveborn/stillborn infants with an NTD; and 3) when electively terminated, NTDaffected infants/fetuses were not included in case ascertainment, NTD risk estimates for factors associated with elective termination appeared biased.
For a population-based cohort from California for 1989-1991 (3 or more years subsequent to the implementation of a state-legislated MSAFP program), liveborn and stillborn infants with an NTD represented 60.4 percent of all clinically recognized NTD-affected pregnancies. Studies from Scotland, Western Europe, Canada, Australia, and the United States, conducted during earlier or similar time periods, found the proportion of recognized liveborn and stillborn NTD cases (anencephaly and/or spina bifida) to represent even smaller percentages of all recognized NTD cases (20) (21) (22) (23) (24) (25) (26) , although findings from Australia were similar. Differences between populations are probably due to variations in access to and utilization of prenatal screening, in choices regarding elective termination procedures, in case ascertainment methods, or in gestational age cut points for definitions of elective terminations and livebirths/stillbirths.
Women who electively terminated NTD-affected pregnancies were disproportionately white, were more educated, had a higher household income, and used vitamins containing folic acid more often. These differences were likely due to variations in access to and utilization of prenatal screening (27) or to choices regarding elective termination procedures, although associations between the latter and sociodemographic factors have not been well studied (28) .
Risk estimates based on liveborn/stillborn infants only were different from those based on the total NTD population. These differences were likely due to selection bias (29, 30) in the liveborn/stillborn only risk estimates introduced by the exclusion from the total case group of electively terminated, NTDaffected pregnancies with select characteristics. It is also possible, however, that women who electively terminated NTD-affected pregnancies actually had different NTD risks from select factors compared with women who delivered liveborn/stillboni infants.
If only livebirths and stillbirths are ascertained for study, can potential selection bias be avoided or minimized? If factors of interest for study are not associated with elective termination, then selection bias due to elective termination should not be present. However, if factors of interest are associated with elective termination (which our data indicate is likely if the factors of interest are associated with almost any of the factors we examined), it would only be possible to reduce selection bias if the exclusion criteria to which the liveborn/stillborn cases were subjected (i.e., exclusion of pregnant women who did not have access to or utilize prenatal NTD screening procedures or who elected not to terminate an NTD-affected infant/fetus) could be mimicked in controls. This would essentially be impossible, however, and if it were possible, the results would only be relevant to a highly select group of pregnant women.
There are several important considerations when interpreting the results of this study. Its strengths are that we used a population-based cohort from over 700,000 births, multiple sources of case ascertainment, and detailed information from structured maternal interviews. Nevertheless, some clinically recognized, NTD-affected pregnancies may not have been ascertained. We were unable to ascertain NTD-affected pregnancies among women who were diagnosed without cytogenetic laboratory work done at a prenatal/ genetic clinic and who electively terminated an NTDaffected pregnancy outside of a hospital setting. The number of cases missed for these reasons is unknown but is likely to be small since an NTD was unlikely to be identified only by ultrasound (without cytogenetic laboratory work done) and then electively terminated in a nonhospital setting much earlier than 18 weeks gestation, and an NTD identified after 18 weeks gestation was likely to have had ultrasound or cytogenetic laboratory work done in a prenatal/genetic clinic before an elective termination procedure was performed. The number of cases missed for these reasons is therefore unlikely to substantially alter study results.
In conclusion, our data indicate that recorded birth prevalences substantially underestimate the total prevalence of clinically recognized NTDs and that these underestimates differ across population subgroups. In addition, exclusion of electively terminated, NTDaffected pregnancies from studied case populations is likely to result in biased risk estimates if factors of interest are associated with elective terminations. Therefore, to monitor trends in NTD prevalence as well as to reduce bias in epidemiologic studies of NTDs, it appears important that all clinically recognized NTDs should be ascertained.
